COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Press Releases

1

May
2015
PRESS
RELEASE

KRS Global Biotechnology, Inc. Announces the Compounded Service of Nitroglycerin.

FDA registered and inspected 503B Human Outsourcing Facility, KRS Global Biotechnology, Inc. who specializes in the preparation of drugs no longer commercially available or in short supply, announces today that they are providing the service of compounded nitroglycerin. BOCA RATON, FL., 7 July 2014 – KRS Global Biotechnology, Inc. is pleased to announce that it […]

1

May
2015
PRESS
RELEASE

KRS Global Reveals That It Has Produced Sterile Injectables in Closed Vial System Since Q3 of 2014

Boca Raton, FL: KRS Global Biotechnology (KRS-GBT), FDA Registered Human Drug Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is excited to reveal closed-system automation already in place. FOR IMMEDIATE RELEASE Colanar Modular Syringe, Vial and Cartridge Filling System – FSM Boca Raton, FL., November 18, 2014 – […]

23

April
2015
PRESS
RELEASE

KRS Global Biotechnology, Inc. Announces FDA Registration and Inspection of Becoming an Outsourcing Facility (via section 503B); Compounding Quality Act

KRS Global Biotechnology, Inc. a specialty pharmacy preparing drugs no longer commercially available or in short supply announces today that they have become a registered Outsourcing Facility under the new Compounding Quality Act. BOCA RATON, FL., 14th April, 2014 – KRS Global Biotechnology, Inc. is pleased to announce that it has been recognized as a […]